Sector dividends Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.82 USD | +1.99% |
|
-1.16% | -6.78% |
Feb. 05 | Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay | MT |
Feb. 05 | Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay | RE |
Yield (Y) | Yield (Y+1) | P/E ratio (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
-.--% | -.--% | -9.9x | 1.58x | 1.28x | 29.47x | 54.64x | 1.14B | ||
0.81% | 0.91% | 28.83x | 3.29x | 3.39x | 14.67x | 21.64x | 13.96B | ||
1.92% | 2.33% | 25.04x | 5.54x | 10.16x | 20.55x | 21.66x | 6.77B | ||
1.09% | 1.22% | 29.04x | 3.19x | 5x | 15.23x | 20.93x | 5.49B | ||
-.--% | -.--% | -12.92x | -50.45x | 7.92x | -21.8x | -14.02x | 5.39B | ||
2.89% | 3.4% | 17.71x | 2.54x | - | - | - | 3.22B | ||
0.57% | 0.63% | 51.46x | 2.07x | 7.76x | 22.85x | 35.81x | 2.5B | ||
-.--% | -.--% | -8.36x | 1.97x | 1.72x | -7.17x | -5.63x | 1.43B | ||
0.74% | 0.92% | 29.05x | 4.68x | 6.6x | 21.85x | 24.16x | 1.24B | ||
2.73% | 3.97% | 18.17x | 1.17x | - | - | - | 1.07B | ||
2.24% | 2.65% | 15.67x | 3.08x | - | - | - | 875M | ||
Average | percentage-no-prefix | percentage-no-prefix | 16.71x | -1.94x | 5.48x | 11.96x | 19.90x | 3.92B | |
Weighted average by Cap. | percentage-no-prefix | percentage-no-prefix | 20.73x | -3.32x | 5.74x | 11.02x | 17.46x |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector dividends